ASPEN PHARMACARE HOLDINGS LIMITED - Aspen interim results and interim results presentation

Aspen interim results and interim results presentation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Company”)




ASPEN INTERIM RESULTS AND INTERIM RESULTS PRESENTATION

Shareholders are advised that Aspen intends releasing its results for the six month period ended
31 December 2014 on 5 March 2015 on SENS. A presentation on the interim results will take place on
Friday, 6 March 2015 in Cape Town at the Investec Specialist Bank Healthcare Conference.

All interested stakeholders are invited to dial into the presentation scheduled for 08h30 (CAT) on
6 March 2015. Participation will be on a listen-in basis only and those interested are requested to dial the
numbers detailed below by no later than 08h15 (CAT) in order to register for the call.

Conference call dial-in details:
South Africa:            0 800 200 648
UK:                      0 808 162 4061
USA & Canada:            1 855 481 5362
Australia:               1 800 350 100
Other countries:         +27 11 535 3600

The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com)
in the Investor Information section shortly before the commencement of the presentation on 6 March
2015.

A playback of this presentation will also be made available after the presentation for a limited time.
Playback details will be published on the Aspen website.

Durban
23 February 2015

Sponsor:
Investec Bank Limited

Date: 23/02/2015 05:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.